Onderzoeker
Suzanne Kaptein
- Disciplines:Microbiologie, Systeembiologie, Laboratoriumgeneeskunde
Affiliaties
- Laboratorium Virologie en Chemotherapie (Rega Instituut) (Afdeling)
Lid
Vanaf2 mei 2006 → Heden
Projecten
1 - 1 of 1
- Ontwikkeling van effectieve strategieën om infecties met het hepatitis E-virus te bestrijden of te behandelenVanaf4 nov 2019 → 4 nov 2023Financiering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
Publicaties
1 - 10 van 65
- Discovery of JNJ-1802, a First-in-Class Pan-Serotype Dengue Virus NS4B Inhibitor(2024)
Auteurs: Suzanne Kaptein, Johan Neyts
Pagina's: 4063 - 4082 - Multiplexed multicolor antiviral assay amenable for high-throughput research(2024)
Auteurs: Li-Hsin Li, Yun-An Huang, Madina Rasulova, Hendrik Jan Thibaut, Sebastiaan ter Horst, Joana Duarte Da Rocha Pereira, Suzanne Kaptein, Pieter Leyssen, Johan Neyts, Kai Dallmeier
- Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studies(2023)
Auteurs: Tania Roskams, Lotte Coelmont, Johan Neyts, Suzanne Kaptein
- Discovery of Acyl-Indole Derivatives as Pan-Serotype Dengue Virus NS4B Inhibitors(2023)
Auteurs: Suzanne Kaptein, Johan Neyts
Pagina's: 8808 - 8821 - Reverse engineering synthetic antiviral amyloids (vol 11, 2832, 2020)(2023)
Auteurs: Emiel Michiels, Rodrigo Gallardo, Laleh Khodaparast, Ladan Khodaparast, Rob van der Kant, Bert Houben, Nikolaos Louros, Suzanne Kaptein, Guy Bormans, Johan Neyts, et al.
- Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates(2023)
Auteurs: Suzanne Kaptein, Kai Dallmeier, Johan Neyts
Pagina's: 678 - + - Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro(2023)
Auteurs: Suzanne Kaptein, Johan Neyts
- A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection(2022)
Auteurs: Rana Abdelnabi, Suzanne Kaptein, Robbert Boudewijns, Steven De Jonghe, Dirk Jochmans, Birgit Weynand, Johan Neyts
- HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect(2022)
Auteurs: Rana Abdelnabi, Suzanne Kaptein, Sebastiaan ter Horst, Leen Delang, Joana Duarte Da Rocha Pereira, Lotte Coelmont, Pieter Leyssen, Kai Dallmeier, Valentijn Vergote, Elisabeth Heylen, et al.
- Perturbation of Alphavirus and Flavivirus Infectivity by Components of the Bacterial Cell Wall(2022)
Auteurs: Lana Langendries, Rana Abdelnabi, Sam Verwimp, Suzanne Kaptein, Leen Delang
Patenten
1 - 10 van 10
- Corona virus binders (Inventor)
- Viral replication inhibitors (Inventor)
- Treatment and prevention of dengue disease (Inventor)
- Treatment and prevention of dengue disease (Inventor)
- Corona virus binders (Inventor)
- Viral replication inhibitors (Inventor)
- Novel viral replication inhibitors (Inventor)
- Viral replication inhibitors (Inventor)
- Viral replication inhibitors (Inventor)
- AVERMECTINS AND MILBEMYCINS FOR THE TREATMENT, PREVENTION OR AMELIORATION OF FLAVIVIRUS INFECTIONS (Inventor)